These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26086075)

  • 1. Survey of pharmacists' subtherapeutic INR management and anticoagulation bridging practices.
    Maxwell WD; Shrader SP; Moore KG; Lu ZK; White SF
    J Clin Pharm Ther; 2015 Oct; 40(5):531-538. PubMed ID: 26086075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
    Baker JW; Pierce KL; Ryals CA
    J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada.
    Krahn AD; Healey JS; Simpson CS; Essebag V; Sivakumaran S; Birnie DH
    Heart Rhythm; 2009 Sep; 6(9):1276-9. PubMed ID: 19716082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.
    Elewa H; Jalali F; Khudair N; Hassaballah N; Abdelsamad O; Mohammed S
    J Eval Clin Pract; 2016 Jun; 22(3):433-8. PubMed ID: 26766552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
    Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
    J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes.
    Elewa HF; AbdelSamad O; Elmubark AE; Al-Taweel HM; Mohamed A; Kheir N; Mohamed Ibrahim MI; Awaisu A
    J Clin Pharm Ther; 2016 Aug; 41(4):403-8. PubMed ID: 27144477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists.
    Airee A; Guirguis AB; Mohammad RA
    Ann Pharmacother; 2009 Apr; 43(4):621-8. PubMed ID: 19318602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL; Hwang JM; Moser LR
    Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of differences in percentage of international normalized ratios in range between pharmacist-led and physician-led anticoagulation management services.
    Gupta V; Kogut SJ; Thompson S
    J Pharm Pract; 2015 Jun; 28(3):249-55. PubMed ID: 24381239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two different models of anticoagulation management services with usual medical care.
    Rudd KM; Dier JG
    Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the role of clinical pharmacists in pre-procedural anticoagulation management.
    Kataruka A; Renner E; Barnes GD
    Hosp Pract (1995); 2018 Feb; 46(1):16-21. PubMed ID: 29283294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care.
    Harrison J; Shaw JP; Harrison JE
    Int J Pharm Pract; 2015 Jun; 23(3):173-81. PubMed ID: 25250655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.